DUBLIN, Feb. 26, 2024 /PRNewswire/ -- The "Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides 2023 to 2027" report has been added to
ResearchAndMarkets.com's offering.
Unlimited growth potential? Genetic Testing has crossed the chasm and is now growing in every area. What are the opportunities? What are the pitfalls?
The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth.
New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. The report includes detailed breakouts for 14 countries and 5 regions.
Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
This research makes you the expert in your organization. Make investment decisions and valuations with confidence using the latest data.
1.1 Genetic Testing - Strategic Situation Analysis & Company Rankings
1.1.1 Selected Genetic Testing Companies Revenue & Growth
1.1.2 Selected Companies Growth Chart
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors
2 Introduction and Market Definition
2.1 Genetic Testing Definition in This Report
2.2 The Genomics Revolution
2.3.1 Revenue Market Size
2.3.3 Non Invasive Pregnancy Testing
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics
2.6 Chromosomes, Genes and Epigenetics
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Instrumentation Supplier
3.1.4 Chemical/Reagent Supplier
3.1.6 Independent Clinical Laboratory
3.1.7 Public National/regional Laboratory
3.1.8 Hospital Laboratory
3.1.9 Physicians Office Lab (POLS)
3.1.11 Certification Body
3.2 Genetic Tests - Types, Examples and Discussion
3.2.1 Preimplantation Genetic Diagnosis - An Emerging Market
3.2.2 Prenatal Diagnosis - New Technologies Create Opportunity
3.2.6 Predictive and Presymptomatic Testing
3.3.1 Hospital's Testing Share
3.3.3 Hospital vs. Central Lab
3.3.4 Physician Office Lab's
3.3.5 Physician's and POCT
4.1 Factors Driving Growth
4.1.1 Genetic Discoveries Creating New Diagnostic Markets
4.1.3 Pharmacogenomics Drives Further Growth
4.1.4 Oncology and Liquid Biopsy Enter New Era
4.1.5 Fertility Practice Growth drives market
4.1.6 Direct to Consumer begins to break out
4.2 Factors Limiting Growth
4.2.1 Increased Competition Lowers Price
4.2.3 Testing usage analysis curtailing growth
4.2.4 Wellness has a downside
4.3 Instrumentation, Automation and Diagnostic Trends
4.3.1 Traditional Automation and Centralization
4.3.2 The New Automation, Decentralization and Point of Care
4.3.3 Instruments Key to Market Share
4.3.4 Bioinformatics Plays a Role
4.3.6 Next Generation Sequencing Fuels a Revolution
4.3.7 NGS Impact on Pricing
4.3.8 Whole Genome Sequencing, A Brave New World
4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
4.3.10 Shifting Role of Diagnostics
5 Genetic Testing Recent Developments
5.1.1 Importance of This Section
5.1.2 How to Use This Section
5.2 Novitas Rescinds Coverage for Multiple Genetic Tests
5.3 PerkinElmer (now Revvity) Becomes Dx Life Science Firm
5.4 New POC Genotyping Tests Based on Electromagnetic Detection
5.7 Genomics England, Aims to Sequence 100K Newborns
5.10 Universal Genetic Testing in Breast Cancer Further Supported 5.11 Aniling Gets CE-IVD Marks for Cancer Sequencing Tests 5.12 MyOme Lands Investment for WGS
5.14 LetsGetChecked to Acquire Veritas Genetics
5.15 Guardant Health Plans New Comprehensive Assay
6 Profiles of Key Companies
6.4 Adaptive Biotechnologies
6.16 Baylor Miraca Genetics Laboratories
6.26 bioMerieux Diagnostics
6.59 Genomics Personalized Health (GPH)
6.76 Integrated Diagnostics
7.1 Global Market by Country
7.2 Global Market by Application
7.3 Global Market by Technology
7.4 Global Market by Product
7.5 Global Market by User
8 Market Sizes by Application
8.1 Newborn Testing Market
8.3 Predictive Testing Market
8.4 Oncology Testing Market
9 Global Genetic Testing Market by Technology
9.3 Cytogenetic Testing Market
10 Global Genetic Testing Market by Product
10.2 Reagents and Kits Market
11 Global Genetic Testing Market by User
11.3 Pharmaceutical Market
11.4 Industrial and Other Market
12 The Future of Genetic Testing
13.1 United States Medicare System: Laboratory Fees Schedule
13.2 The Most Used IVD Assays
13.3 The Highest Grossing Assays
For more information about this report visit https://www.researchandmarkets.com/r/xnebxx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets